Envoy Medical, Inc. (COCH) Form 10-Q — Nov 5, 2026
Envoy Medical reported Q3 2026 net revenues of just $66 thousand against a net loss of $3.9 million, with nine-month net loss of $14.3 million and an accumulated deficit of $331.6 million.
Key figures
- Revenue
- 66000
- Total Assets
- 19158000
- Cash Position
- 14570000
- Shares Outstanding
- 7744488
- Q3 revenue
- 66000
- Pma decision timing
- late Q4 2027 to H1 2028
- Reverse split ratio
- 1:10
- Potential warrant proceeds
- 48000000
- Preferred unpaid dividends sponsor
- 4541000
- February 2026 offering net proceeds
- 27782000
AI analysis
Red flags6 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.